ANVS

ANVS

USD

Annovis Bio Inc. Common Stock

$1.890-0.060 (-3.077%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.950

Hoch

$2.029

Tief

$1.890

Volumen

0.22M

Unternehmensfundamentaldaten

Marktkapitalisierung

46.2M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.60M

Börse

NYQ

Währung

USD

52-Wochen-Spanne

Tief $1.11Aktuell $1.890Hoch $8.93

Ähnliche Nachrichten

GlobeNewswire

Annovis Announces $6 Million Registered Direct Offering of Common Stock

MALVERN, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases

Mehr anzeigen
Annovis Announces $6 Million Registered Direct Offering of Common Stock
GlobeNewswire

Annovis Announces Novel Biomarker Data in Alzheimer's Patients Supporting Buntanetap's Potential as a Disease-Modifying Treatment

MALVERN, Pa., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases

Mehr anzeigen
Annovis Announces Novel Biomarker Data in Alzheimer's Patients Supporting Buntanetap's Potential as a Disease-Modifying Treatment
GlobeNewswire

Annovis Appoints Mark Guerin as Chief Financial Officer

MALVERN, Pa., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc.

Mehr anzeigen
Annovis Appoints Mark Guerin as Chief Financial Officer